OrthoPediatrics Corp. The company is headquartered in Warsaw, Indiana.
| Revenue (TTM) | $264.13M |
| Gross Profit (TTM) | $194.84M |
| EBITDA | $1.13M |
| Operating Margin | -4.97% |
| Return on Equity | -9.84% |
| Return on Assets | -2.68% |
| Revenue/Share (TTM) | $11.07 |
| Book Value | $12.99 |
| Price-to-Book | 2.58 |
| Price-to-Sales (TTM) | 3.19 |
| EV/Revenue | 3.522 |
| EV/EBITDA | 382.20 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 18.60% |
| Shares Outstanding | $26.11M |
| Float | $18.22M |
| % Insiders | 29.69% |
| % Institutions | 68.91% |
Volatility is currently expanding
WARSAW, Ind., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences, held in New York, NY.
OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Record Third Quarter 2026 Revenue of $72.7 Million , Up 19% Year-over-Year
New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction New addition to the Pediatric Nailing Platform expands options for pediatric femoral trauma and deformity correction
WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2026 financial results on Tuesday, October 27, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 27, 2026 at 4:30 p.m. ET to discuss the results.
WARSAW, Ind., Oct. 07, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with a new product launch, the OPSB® Knee 'TractorFIX contracture management orthosis.
Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries
WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP).
Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology
OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on KIDS and any ticker you trade — then tracks every position and per-strategy win rate.
